Follow-up Visit of High Risk Infants
Launched by NICHD NEONATAL RESEARCH NETWORK · Feb 2, 2001
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Follow-up Visit of High Risk Infants trial is studying how certain factors during pregnancy and after birth affect the development of infants who were born extremely early or with very low birth weight. In this study, babies who were born before 27 weeks of pregnancy and are now between 18 and 26 months old will receive important assessments to check their growth and development. This includes looking at their brain development, senses, and overall abilities. The goal is to gather information that can help us understand what influences their development and how we can improve care for these vulnerable infants.
To be eligible for this study, infants must have been born at one of the participating centers and must be under 27 weeks gestational age. Additionally, they need to be part of other related studies by the NICHD Neonatal Research Network. If chosen to participate, families can expect to bring their child in for assessments that will help researchers gather valuable information about their child’s development. This study is currently recruiting participants, and it aims to provide insights that could lead to better outcomes for high-risk infants in the future.
Gender
ALL
Eligibility criteria
- • Infants inborn at NRN centers
- • \<27 weeks gestational age
- • Infants enrolled in one or more additional NICHD NRN Follow-up studies. For infants that do not meet the inclusion criteria above, inclusion and exclusion criteria are determined by the criteria for the additional trial(s). In these cases, infants that are larger than 1,000 grams and/or older than 27 weeks may be included in the FU Study.
- • Note: These inclusion criteria were changed as of 1/1/2008. Prior to this date, infants with birth weights between 401 and 1500 grams who were admitted to NRN NICUs within 14 days of birth were included in the database.
About Nichd Neonatal Research Network
The NICHD Neonatal Research Network (NNR) is a premier collaborative research initiative sponsored by the National Institute of Child Health and Human Development (NICHD). It focuses on advancing the understanding and treatment of neonatal conditions through rigorous clinical trials and studies. By uniting leading medical centers and researchers, the NNR aims to improve neonatal health outcomes, enhance care practices, and contribute to evidence-based guidelines. The network emphasizes multidisciplinary approaches, innovative methodologies, and patient-centered research, making significant strides in the field of neonatal care and contributing valuable insights to pediatric medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rochester, New York, United States
Philadelphia, Pennsylvania, United States
Iowa City, Iowa, United States
Kansas City, Missouri, United States
Durham, North Carolina, United States
Detroit, Michigan, United States
Palo Alto, California, United States
New Haven, Connecticut, United States
Miami, Florida, United States
Atlanta, Georgia, United States
Indianapolis, Indiana, United States
Cambridge, Massachusetts, United States
Albuquerque, New Mexico, United States
Durham, North Carolina, United States
Cincinnati, Ohio, United States
Cleveland, Ohio, United States
Providence, Rhode Island, United States
Memphis, Tennessee, United States
Dallas, Texas, United States
Houston, Texas, United States
San Diego, California, United States
Boston, Massachusetts, United States
Birmingham, Alabama, United States
Washington, District Of Columbia, United States
Los Angeles, California, United States
Charlotte, North Carolina, United States
Columbus, Ohio, United States
Salt Lake City, Utah, United States
San Diego, California, United States
Chicago, Illinois, United States
Jackson, Mississippi, United States
Patients applied
Trial Officials
Abbot R. Laptook, MD
Principal Investigator
Brown University, Women & Infants Hospital of Rhode Island
Michele C. Walsh, MD MS
Principal Investigator
Case Western Reserve University, Rainbow Babies and Children's Hospital
C. Michael Cotten, MD, MHS
Principal Investigator
Duke University
David P. Carlton, MD
Principal Investigator
Emory University
Greg M. Sokol, MD
Principal Investigator
Indiana University
Abhik Das, PhD
Principal Investigator
RTI International
Krisa P. Van Meurs, MD
Principal Investigator
Stanford University
Brenda B. Poindexter, MD
Principal Investigator
Children's Hospital Medical Center, Cincinnati
Waldemar A. Carlo, MD
Principal Investigator
University of Alabama at Birmingham
Edward F. Bell, MD
Principal Investigator
University of Iowa
Kristi L. Watterberg, MD
Principal Investigator
University of New Mexico
Myra H. Wyckoff, MD
Principal Investigator
University of Texas, Southwestern Medical Center at Dallas
Jon E Tyson, MD, MPH
Principal Investigator
The University of Texas Health Science Center, Houston
Bradley A. Yoder, MD
Principal Investigator
University of Utah
Seetha Shankaran, MD
Principal Investigator
Wayne State University
William E. Truog, MD
Principal Investigator
Children's Mercy Hospital Kansas City
Pablo J. Sanchez, MD
Principal Investigator
Research Institute at Nationwide Children's Hospital
Uday Devaskar, MD
Principal Investigator
University of California, Los Angeles
Carl T D'Angio, MD
Principal Investigator
University of Rochester
Eric C Eichenwald, MD
Principal Investigator
University of Pennsylvania
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials